Journal Pre-proof Midtrimester amniotic fluid from healthy pregnancies has no microorganisms using multiple methods of microbiologic inquiry Yu Liu, PhD, Xiang Li, PhD, Baoli Zhu, PhD, Haijuan Zhao, MS, Qubo Ai, MS, Yulong Tong, MS, Shengtang Qin, PhD, Ye Feng, MD, Yutong Wang, MD, Shuxian Wang, PhD, Jingmei Ma, MD, PhD, Huixia Yang, MD, PhD PII:
S0002-9378(20)30111-3
DOI:
https://doi.org/10.1016/j.ajog.2020.01.056
Reference:
YMOB 13097
To appear in:
American Journal of Obstetrics and Gynecology
Received Date: 29 October 2019 Revised Date:
27 January 2020
Accepted Date: 27 January 2020
Please cite this article as: Liu Y, Li X, Zhu B, Zhao H, Ai Q, Tong Y, Qin S, Feng Y, Wang Y, Wang S, Ma J, Yang H, Midtrimester amniotic fluid from healthy pregnancies has no microorganisms using multiple methods of microbiologic inquiry, American Journal of Obstetrics and Gynecology (2020), doi: https://doi.org/10.1016/j.ajog.2020.01.056. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier Inc.
1
Midtrimester amniotic fluid from healthy pregnancies has no
2
microorganisms using multiple methods of microbiologic inquiry
3 4
Yu Liu, PhD1,2, Xiang Li, PhD3, Baoli Zhu, PhD4, Haijuan Zhao, MS3, Qubo Ai, MS3,
5
Yulong Tong, MS1,2, Shengtang Qin, PhD1,2, Ye Feng, MD1,2, Yutong Wang, MD1,2,
6
Shuxian Wang, PhD1,2, Jingmei Ma, MD, PhD1,2, Huixia Yang, MD, PhD1,2
7 8
1
9
China.
Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing,
10
2
11
Beijing, China.
12
3
13
4
14
Microbiology, Chinese Academy of Science, Beijing, China.
Beijing Key Laboratory of Maternal Fetal Medicine of Gestational Diabetes Mellitus,
COYOTE Medical Laboratory, Beijing, China. Key Laboratory of Pathogenic Microbiology and Immunology/ Institute of
15 16
Declaration of interests: The authors report no conflicts of interest.
17 18
Corresponding authors: Jingmei Ma,
[email protected]
19
Huixia Yang,
[email protected]
20 21
Funding: The research was financially supported by the National Key
22
Technologies R&D Program (no. 2016YFC1000303), National Natural
23
Science Foundation of China (no. 81671483) and Beijing Municipal
24
Natural Science Foundation (no. 7171011, S150002).
25 26
Abstract word counts: 268
27
Main text Word counts: 4653
28 29 30 31 32 33 1
34
Condensation and short version of title
35 36
Condensation: With multiple methods of microbiologic inquiry, no evidence was
37
found to support the presence of bacteria in the midtrimester amniotic fluid of normal
38
pregnancies.
39 40
Short Title: The absence of bacteria in midtrimester amniotic fluid
41 42
AJOG at a Glance:
43
Why was the study conducted?
44
To determine whether bacteria are present in the midtrimester amniotic fluid of
45
patients who subsequently had a normal pregnancy outcome.
46 47
Key findings
48
• Amniotic fluid did not contain any cultivable bacteria or genital mycoplasmas.
49
• There was no evidence of bacterial DNA using molecular microbiologic techniques
50
(quantitative real-time PCR and 16S rRNA gene sequencing).
51 52
What does this study add to what is already known?
53
This study demonstrates that the midtrimester amniotic fluid of normal pregnancies
54
does not contain bacteria using multiple methods of microbiologic inquiry.
55 56
Key words: bacteria; culture; cytokines; pregnancy outcome; 16S rRNA gene
57
sequencing; 16S rRNA gene copies
58 59 60 61 62 63 64 65 66 2
67
Abstract
68 69
BACKGROUND: There is controversy about whether the amniotic fluid contains
70
bacteria. Using sequencing-based methods, recent studies report that the amniotic
71
fluid is colonized by microorganisms. However, background-contaminating DNA might
72
lead to false-positive findings when such a low microbial biomass sample is
73
examined.
74 75
OBJECTIVE: To determine whether the midtrimester amniotic fluid of patients who
76
subsequently had normal pregnancy outcomes contains a microbial signature.
77 78
STUDY DESIGN: In this prospective cohort study, 42 amniotic fluid samples were
79
collected from 37 pregnancies (5 twin and 32 singletons) during genetic
80
amniocentesis in the midtrimester. The subsequent pregnancy outcomes of all the
81
participants were followed. Multiple methods were used to detect the presence of
82
microorganisms in this study, including cultivation, quantitative real-time polymerase
83
chain reaction (qPCR) and 16S ribosomal RNA (rRNA) gene sequencing. Multiple
84
positive controls (n=16) served as quality controls, including 3 adult fecal samples, 4
85
vaginal swabs and 9 artificial bacterial communities, and run in parallel with negative
86
controls (n=12), including 4 from the hospital operating room and 8 from the laboratory,
87
to account for background-contaminating DNA during each step of the experiments.
88 89
RESULTS: (1) No bacteria under anaerobic or aerobic conditions or genital
90
mycoplasmas were cultured from any of the amniotic fluid samples. (2) Quantitative
91
PCR did not reveal greater copy numbers of 16S rRNA gene in amniotic fluid samples
92
than in negative controls. (3) 16S rRNA gene sequencing did not indicate significant
93
difference in the microbial richness or community structures between amniotic fluid
94
and negative controls.
95 96
CONCLUSION: With multiple methods of microbiologic inquiry, no microorganisms
97
were identified in the midtrimester amniotic fluid of healthy pregnancies with a normal
98
pregnancy outcome.
99 3
100 101
Introduction
102
Based on culture method, the intra-amniotic cavity has traditionally been viewed as
103
sterile for more than 100 years. However, this “sterile womb” paradigm has been
104
challenged by recent studies based on culture-independent sequencing techniques.
105
The molecular evidence of unique bacterial communities could be detected in the
106
amniotic fluid (AF),1-4 placenta,4-10 endometrium11,12 and meconium13,14 of term
107
healthy pregnancies .
108 109
Microbial invasion of the amniotic cavity (MIAC) resulting in intra-amniotic infection
110
has been associated with adverse pregnancy outcomes,15-17 such as spontaneous
111
preterm
112
histological/clinical chorioamnionitis.22,23 An ascending pathway is considered the
113
most common route of MIAC, given the direct evidence that microorganisms isolated
114
from amniotic fluid of women with intra-amniotic infection are present in the lower
115
genital tract.24
birth,15,18,19
preterm
premature
rupture
of
membranes20,21
and
116 117
Considering the unavoidable occurrence of environmental or reagent contamination
118
during the entire experimental process,25,26 multiple rigorous experimental controls
119
are urgently required when such a low microbial biomass sample is studied.27 Several
120
subsequent studies found the microbial profiles of AF28,29 and placenta30-32 to be
121
indistinguishable from negative controls, re-establishing controversy regarding the “in
122
utero colonization hypothesis”.25
123 124
As pregnancy progresses, the uterus changes from an early proinflammatory
125
condition to an antiinflammatory condition in the second trimester and then back to a
126
proinflammatory condition before the onset of labor.33 The intra-amniotic microbial
127
profile might change as the cervix shortens and dilates. Nevertheless, most studies
128
collected the samples at the time of delivery.
129 130
Using
131
polymerase chain reaction (qPCR) and16S rRNA gene sequencing, we prospectively
132
conducted a prospective cohort study to investigate the presence of microorganisms
multiple
inquiry
methods,
including
4
cultivation,
quantitative
real-time
133
in the midtrimester AF of 37 women in parallel with multiple negative and positive
134
controls and followed their subsequent pregnancy outcomes.
135
Materials and Methods
136
Study design
137
This prospective cohort study was conducted in Peking University First Hospital from
138
May 2018 to March 2019. Women undergoing amniocentesis for prenatal diagnosis
139
between 19 and 22 weeks of gestation were recruited for the study. The exclusion
140
criteria were as follows: (1) fetal malformation; (2) clinical infection and antibiotic
141
treatment within 2 weeks; and (3) refusal to participate. This study was reviewed and
142
approved by the institutional ethics committee of Peking University First Hospital
143
(2015[886]), and all the participants provided the written informed consent.
144 145
Ultimately, 37 women (5 with dichorionic diamniotic twin pregnancies and 32 with
146
singleton pregnancy) were enrolled, and 42 AF samples were collected by
147
amniocentesis (Figure 1). The clinical characteristics were obtained via electronic
148
medical records, including the history of spontaneous or in vitro fertilization (IVF)
149
conception and pregnancy outcomes (Table S1).
150 151
To reflect the potential DNA contamination during the experimental procedure, 12
152
negative controls were designed, including (1) sterile saline solution (9 mg/mL NaCl)
153
collected in the hospital operating room (n=4), serving as sampling controls; (2) DNA
154
extraction kit buffers (n=4) collected in the laboratory, without AF samples but
155
processed exactly as AF samples, serving as extraction controls; (3) PCR
156
amplification reagents (n=2) and DNA-free water (n=2) without an extraction protocol,
157
serving as amplification controls and blank controls, respectively. Moreover, 16
158
positive controls consisting of adult stool specimens (n=3), vaginal swabs (n=4), and
159
artificial bacterial communities (n=9) spiked into AF were used as experimental quality
160
controls. Artificial bacterial communities 1-7 contained various gram-positive and
161
-negative bacteria with known numbers of colony-forming units (CFUs). Artificial
162
bacterial communities 7 was serially diluted to a 10-1 dilution (artificial bacterial
163
communities 8) and 10-2 dilution (artificial bacterial communities 9) for a lowest limit of
164
detection (Table S2). Five gradients of plasmids from Escherichia coli were set up to
165
generate the qPCR standard curve. The presence of microorganisms was determined 5
166
using (1) cultivation, (2) qPCR of the 16S rRNA gene, (3) 16S rRNA gene sequencing.
167
In summary, 46 samples were subjected to cultivation, 64 samples were subjected to
168
qPCR, 68 samples were subjected to 16S rRNA gene sequencing, and 39 AF
169
samples were subjected to cytokines detection (Figure 1). The detailed information is
170
presented in Table S3.
171 172
Clinical definition and pregnancy outcomes
173
Gestational age was determined by the date of the last menstrual period and
174
confirmed by ultrasound examination. Gravidity and parity were recorded according to
175
the current admission status. Preterm birth is defined as birth occurring prior to 37
176
gestational weeks, including spontaneous and iatrogenic preterm birth. Premature
177
rupture of membranes (PROM) is defined as spontaneous rupture of membranes
178
prior to the onset of labor. Preterm PROM (PPROM) occurs before 37 gestational
179
weeks. The diagnosis of histologic chorioamnionitis is based on the presence of acute
180
inflammatory changes in the chorionic plate and/or in the chorioamniotic membrane,
181
as previously described.34,35
182 183
Sample collection and preparation
184
Amniocentesis was performed in a sterile operating room, and sample preparation
185
was carried out by the same researcher wearing sterile mask and gloves. After
186
centrifugation at 1300 × g (10 minutes, room temperature), AF supernatants were
187
collected and divided into five aliquots in a biosafety cabinet (BSC-1500IIB2-X,
188
Biobase, Shandong, China) for further analysis. Three aliquots were placed in sterile
189
tubes and transported to the laboratory for anaerobic, aerobic and genital
190
mycoplasma cultures; the remaining two aliquots were immediately stored at -80°C
191
for molecular sequencing and cytokine detection. Four negative controls were
192
collected in the same operating room following the same sampling and aliquoting
193
procedures.
194 195
Bacterial culture
196
Each aliquot of sample (2-3 mL) was injected into a BD Bactec Lytic/10 Anaerobic/F
197
Culture Vial and a BD Bactec Plus Aerobic/F Culture Vial (Becton, Dickinson and
198
Company, USA) using a sterile syringe. The entire procedure was performed in a 6
199
biological safety cabinet, and the vials were incubated in a Bactec FX Instrument
200
(Becton, Dickinson and Company, USA) at 35°C for 5 days according to the
201
manufacturer’s protocol.36
202 203
The genital mycoplasma cultivation assay (Mycoplasma IES, Autobio, Zhengzhou,
204
China) was also performed under the manufacturer’s instructions.37 In brief, 300 µL of
205
the amniotic fluid were transferred into the reconstituted medium. Afterward, 100 µL of
206
the suspension were inoculated into the wells of the strip. All the strips were incubated
207
at 35°C ~37°C for 24 h, and the appearance of a red color indicated a positive
208
reaction and microbial growth.
209 210
DNA extraction
211
DNA extraction was performed in a biological safety cabinet under the standard
212
protocol for microbial analysis with a QIAamp DNA Stool Mini kit (Qiagen, Hilden,
213
Germany). During the entire experimental process, the study personnel wore sterile
214
laboratory coats, hairnets, face masks and sleeves. DNA concentrations of the AF
215
samples and controls were measured with a Qubit 3.0 Fluorometer (Q32866, Life
216
Technologies, Carlsbad, CA), and purified DNA was stored at -20°C .
217 218
16S rRNA qPCR
219
The bacterial DNA copy number was detected by TaqMan quantitative PCR of the
220
V3-V4
221
5’-ACTCCTAYGGGRBGCASCAGT-3’;
222
5’-CCTAGCTATTACCGCGGCTGCT-3’;
223
5’-6FAMCGGCTAACTMCGTGCCAGBHQX-3’. A 20 µL reaction contained 10 µL of
224
Premix Taq (2x) Mix (Takara, Shiga, Japan), 1 µL of DNA, and 5 µmol of primer and
225
probe. Amplifications were performed with an initial denaturation at 95°C for 2 minutes,
226
followed by 40 cycles of denaturation at 94°C for 5 seconds and annealing at 60°C for
227
30 seconds. All reactions were performed using a Roche 480 Real Time PCR
228
instrument (Roche, Basel, Switzerland). A plasmid containing the 16S PCR amplicon
229
from E. coli was serially diluted from 105 copies to 10 copies to generate a standard
230
curve. Each sample was amplified in duplicate.
region
of
the
16S
rRNA
gene
using
the
following:
primer-F, primer-R, probe,
231 7
232
16S rRNA gene sequencing
233
The 16S rRNA gene V3-V4 region was chosen for Illumina sequencing to identify the
234
bacterial taxonomic composition by a two-step PCR. Extracted DNA was first
235
amplified by digital droplet PCR (ddPCR). Droplet generation, droplet transfer, and
236
plate sealing were performed according to the protocol. DNA was amplified with 1x
237
KAPA HiFi Master Mix (16SAFP02, Coyote, Beijing, China), 0.2 µmol of each primer
238
(primer-F:
239
5’-GGACTACNNGGGTATCTAAT-3’), and 9 µL of DNA. The conditions were as
240
follows: 95°C for 3 minutes, followed by 30 cycles of denaturation at 98°C for 15
241
seconds, annealing at 50°C for 50 seconds, and exte nsion at 72°C for 30 seconds,
242
with 1 cycle at 72°C for 10 minutes. All reactions were performed using a 96-well PCR
243
instrument (Coyote), and amplification products were purified with VAHTS clean
244
beads (Na44-02, Coyote). After attachment of barcode adapters (16SAFP03, Coyote),
245
the second PCR was performed under the same conditions as above, with only 8
246
cycles and an increased annealing temperature of 58°C for 30 seconds. Amplicon
247
libraries were purified with VAHTS clean beads (Na44-02, Coyote) and quantified with
248
a Qubit dsDNA HS Assay Kit (Q32851, Life Technologies). The final library was
249
sequenced using the Illumina HiSeq 2500 platform (San Diego, CA).
5’-CCTAYGGGRBGCASCAG-3’;
primer-R:
250 251
Multiplex bead array assay for cytokines
252
The AF concentrations of the following 21 cytokines were measured with an EMD
253
Millipore Milliplex Kit (HCYTO-60K, 21X-Milliplex, Billerica, MA, USA) according to the
254
manufacturer’s instructions. Thirteen proinflammatory cytokines [transforming growth
255
factor alpha (TGF-α), granulocyte colony stimulating factor (G-CSF), interferon
256
gamma (IFN-γ), interleukin-12P40 (IL-12P40), IL-15, sCD40L, IL-17A, IL-1α, IL-1β,
257
IL-2, IL-6, IL-7, and vascular endothelial growth factor (VEGF)], 3 antiinflammatory
258
cytokines [fibroblast growth factor-2 (FGF-2), IL-10, and IL-4], and 5 chemokines
259
[fractalkine, macrophage-derived chemokine (MDC), IL-8, interferon gamma-induced
260
protein 10 (IP-10), and macrophage inflammatory protein (MIP)-1α] were quantified.
261
Briefly, each well of 96-well plates was loaded in duplicate with 25 µL of assay buffer
262
and 25 µL of standard, control, or AF supernatant. Next, 25 µL of magnetic beads
263
were added into each well and incubated for 2 hours at room temperature; the wells
264
were washed twice with 200 µL of wash buffer, followed by the addition of 25 µL of 8
265
detection antibody. The plates were then incubated for 1 hour at room temperature,
266
after which 25 µL of streptavidin-phycoerythrin were added to each well and incubated
267
for 30 minutes at room temperature. The plates were washed twice more with wash
268
buffer, and 150 µL of the drive fluid were added into each well for measurement using
269
a Luminex Magpix instrument (Thermo Scientific, Waltham, MA). Standard curves
270
were generated, and the values of samples were calculated from the curve.
271 272
Statistical analysis
273
The cycle threshold (CT) values of the qPCR assay, defined as the number of thermal
274
cycles required for the detection threshold, were converted to copy numbers
275
according to the standard curve. Sequences of the 16S rRNA gene were clustered
276
using QIIME with 97% nucleotide similarity and taxonomically classified using the
277
Greengenes database. Paired reads were merged with flash software with a
278
maximum of 10% allowed between the number of mismatched base pairs and the
279
overlap length. Sequencing of DNA extracts yielded 3,884,287 sequences for AF
280
samples, 2,149,237 sequences for positive controls, and 3,366 sequences for
281
negative controls. Based on 97% nucleotide similarity, the sequences clustered into
282
400 operational taxonomic units (OTUs) for AF samples, 2,010 OTUs for positive
283
controls, and 13 OTUs for negative controls. The Good’s coverage values of all but 1
284
AF sample exceeded 99.8%. The exception was 99.7% (S18). Good’s coverage
285
values of all positive controls and negative controls exceeded 99.9%. For analyses of
286
alpha diversity, individual sample libraries were subsampled using the cutoff value of
287
30,000, and samples with fewer than 30,000 sequences were not subsampled.
288 289
Bacterial compositions were visualized with a heat map, which was generated via
290
Seaborn, a Python data visualization library. Alpha diversity was evaluated with the
291
Chao1 and Simpson indexes. Beta diversity was assessed by unweighted UniFrac
292
distance matrices and visualized by principal coordinates analysis (PCoA), with 1000
293
permutations, and statistically calculated by the nonparametric multivariate analysis of
294
variance (NPMANOVA) methods using the Adonis function in the R package vegan.
295
The metric variable was shown as the mean ± standard deviation (SD) or median
296
(interquartile range), and compared by Student’s t test or Mann-Whitney U test
297
according to the normality of the data distribution. Chi-square and Fisher’s exact tests 9
298
were used to compare of proportions of analytes. A P value < 0.05 was considered
299
significant. GraphPad Prism version 7.0 (GraphPad Software, San Diego, CA) was
300
used for the statistical and graphical analyses.
301 302
Results
303
Clinical characteristics
304
The demographic and clinical characteristics of all the patients are shown in Table 1.
305
Among the 37 women, 14 conceived with IVF (5 with dichorionic diamniotic twins) and
306
23 conceived spontaneously. One woman with twin gestation (subject ID 3) had an
307
intrauterine fetal demise of one twin at 22 weeks. Two (subject IDs 4 and 7) of four
308
cases of preterm birth had PPROM and delivered at 36 and 30 gestational weeks,
309
respectively, and the histologic acute chorioamnionitis (stage 2, grade 2) was
310
identified in subject ID 4. One woman (subject ID 10) delivered electively at 36
311
gestational weeks for gestational hypertension, and another one (subject ID 13)
312
delivered electively at 33 gestational weeks due to preeclampsia (Table S1).
313 314
Bacterial cultures
315
All the AF samples and sampling controls did not yield any bacterial cultivars under
316
aerobic or anaerobic conditions, nor the growth of genital mycoplasmas.
317 318
Real-time qPCR for 16S rRNA gene copy number
319
To quantify the microbial biomass in AF samples, we used the qPCR assay to
320
measure the copy number of the 16S rRNA gene. A standard curve over a range of 10
321
to 105 gene copies was generated by the linear regression analysis of an E. coli
322
plasmid (Figure 2A, slope= -3.7, R2 =0.99). Compared with stool samples [median
323
(min, max), 2.4x108 (2.1x108, 2.6x108) copies/µL] and vaginal swabs [4.5x107 (1.3x107,
324
7.6x107) copies/µL], AF samples contained very low bacterial biomass [553 (32,
325
24106) copies/µL]. Considering the potential contamination, we assessed the 16S
326
rRNA gene copy number in the negative controls. Although the AF samples contained
327
higher numbers of 16S gene copies than the extraction [22 (4, 287) copies/µL,
328
Mann-Whitney U test; U=9, P<0.01] and blank [14 (4, 22) copies/µL, U=0, P<0.001]
329
controls, no significant difference was observed between the AF samples and the
330
sampling controls [566 (453, 659) copies/µL, U=79.5, P=0.87] (Figure 2B). 10
331 332
16S rRNA gene sequencing
333
As the positive controls, the taxonomic composition of each artificial bacterial
334
communities was consistent with expectations (Figure 3A-G). The relative
335
abundances of bacterial compositions were highly similar among artificial bacterial
336
communities 7, 8 and 9, except for Micrococcus, which could not be accurately
337
measured in artificial bacterial communities 9 (Figure 3G), indicating the lowest
338
detection limit. Therefore, the feasibility and reliability of the sequencing data were
339
ensured. Except for 1 extraction control and 2 amplification controls, we identified
340
sequenced reads in 95.6% (65/68) of the samples. Five AF samples and 3 extraction
341
controls were removed from further analyses because no bacterial OTU was
342
annotated in these samples.
343 344
The bacterial richness of AF samples was significantly lower than that of stool (Figure
345
4A, Mann-Whitney U test, Chao1 index, U=0, P<0.001; 4B, Simpson index, U=2,
346
P<0.001). However, no significant difference was found between AF samples and
347
sampling controls (Figure 4A, Chao1 index, U=35, P=0.37; 4B, Simpson index,
348
U=36.5, P=0.42). To assess bacterial community structure, PCoA analysis based on
349
the unweighted UniFrac distance was performed. In general, the samples clustered
350
according to sample types (Figure 4C). Stool and vaginal swabs were distinct from AF
351
samples (NPMANOVA, stool vs AF: F=5.547, P<0.001; vaginal swabs vs AF: F=3.055,
352
P=0.001) and sampling controls (stool vs sampling controls: F=6.308, P=0.022;
353
vaginal swabs vs sampling controls: F=2.683, P=0.027). Similarly, no significant
354
difference in bacterial community structure was observed between the AF samples
355
and sampling controls (F=1.166, P=0.243).
356 357
To identify the potential bacterial OTUs unique to AF samples, a secondary analysis
358
was performed to eliminate the background signals in the negative controls. The
359
sequenced data were more stringently filtered (with fewer than 10 identical sequences
360
were filtered) compared to the primary analyses (with fewer than 5 identical
361
sequences were filtered). Eventually, 3 stool samples and 4 vaginal swabs, as well as
362
13 AF samples, met this threshold and possessed at least one OTU.
363 11
364
Given the absence of bacterial OTUs at the genus level, 3 AF samples (S21, S2, S10)
365
were excluded from further analysis. In the remaining 17 cases, 22 predominant
366
OTUs at the genus level were identified based on a relative abundance >1% (Figure
367
5). Among the 22 bacterial OTUs, 14 were found in AF samples, and 10 of them
368
(Pseudonocardia,
369
Bifidobacterium, Corynebacterium, Bdellovibrio and Iamia) were identified in only one
370
AF sample, suggesting that they were likely contaminants rather than genuine signals.
371
In addition, Bdellovibrio and Iamia are usually found in soil and plants and
372
Pseudonocardia and Dialister are usually found in soil,38 which are unexpected
373
findings for the human amniotic cavity from an ecological perspective. In contrast,
374
each of the remaining four bacterial OTUs, Bacteroides, Propionibacterium,
375
Faecalibacterium and Ruminococcus, was found in more than two of the AF samples.
376
which was considered ecologically plausible, as the origin might be the human vagina,
377
gut or skin. The 4 bacterial OTUs were identified in nine AF samples, including 8 (S3,
378
S4, S7, S13, S14, S16, S18 and S19) from the IVF conception and 1 (S20) from the
379
spontaneous conception (Figure 5).
Adhaeribacter,
Dialister,
Roseburia,
Delftia,
Sutterella,
380 381
Cytokine concentrations in amniotic fluid
382
To investigate any inflammatory response to the aforesaid bacterial signals, the
383
cytokine profile of AF samples was further assessed. In general, all the cytokines
384
concentrations of AF samples either with (n=7) or without (n=32) bacterial signals
385
were both considerably low, when compared with these of patients with
386
microbial-associated intra-amniotic inflammation (Table S4).39 Taking IL-6 as an
387
example, the AF concentration ≥2.6 ng/mL is used to define the intra-amniotic
388
inflammation. However, the median concentration of IL-6 of 39 AF samples was 105.5
389
pg/mL, ranged from 12.3 pg/mL to 736.9 pg/mL, which was much lower than the cutoff
390
value of intra-amniotic inflammation.
391 392
Pregnancy outcomes of women who harbored bacterial signals
393
Subsequently, we investigated the pregnancy outcomes of the women who harbored
394
the bacterial signals (Table 2). Among them, 7 women conceived through IVF and 1
395
woman conceived spontaneously. One woman (subject ID 3) had a single intrauterine
396
fetal demise at 22 weeks. Two women underwent preterm birth: one (subject ID 10) 12
397
delivered electively at 36 gestational weeks for gestational hypertension, and the
398
other (subject ID 13) delivered electively at 33 gestational weeks for preeclampsia
399
without any signs of inflammatory response during the histopathologic examination.
400
Using criteria previously described,39-41 one woman (subject ID 15) was diagnosed
401
with clinical chorioamnionitis at the time of delivery according to the presence of fever
402
(temperature was 38°C) accompanied by the symptoms of tachycardia (heart rate
403
was 106 beats/min) and leukocytosis (leukocyte count was 23,000 cells/mm3), but no
404
acute inflammatory responses were found from histopathology. No adverse
405
pregnancy outcomes were reported in remaining women.
406 407
Comment
408
Principal findings of the study
409
The main findings included (1) cultivation did not yield viable bacteria or genital
410
mycoplasmas in any AF samples; (2) qPCR did not distinguish the AF samples from
411
the negative controls based on 16S rRNA gene copy number; (3) 16S rRNA gene
412
sequencing did not reveal a difference in microbial composition or community
413
structure between AF samples and negative controls. The identification of
414
Bacteroides, Propionibacterium, Faecalibacterium and Ruminococcus against
415
negative controls, although intriguing, was not supported by the absence of
416
intra-amniotic inflammation in the cytokines detection. Overall, we did not find the
417
consistent evidence that the midtrimester AF of normal pregnancy contains
418
microorganisms.
419 420
Controversial views regarding intra-amniotic microorganisms
421
A groundbreaking publication in 20145 claimed that the placentae from uncomplicated
422
pregnancies harbor a unique microbiome that is similar to the microbiota of the human
423
oral cavity according to 16S rRNA gene sequencing, as well as metagenomics
424
sequencing in a subset of samples. This finding stimulated a wave of research
425
exploring the microbiota in placenta,4,6,10,42,43 AF,1-4 and uterus tissue,1,44,45,
426
challenging
427
accumulating studies have argued that the unavoidable background DNA
428
contamination during the experimental processes might lead to false-positive
429
findings.46-49 Recently, Rowlands et al50 found the midtrimester AF samples were
the
long-standing
“sterile
13
womb”
dogma.
However,
gradually
430
negative for the presence of bacteria, using the species-specific and broad-range
431
PCR techniques. Furthermore, Lim et al29 failed to identify a unique microbiota in AF
432
samples from healthy pregnancies that differs from negative controls. In a recent
433
study of 10 uncomplicated pregnancies with intact amniotic membranes, no significant
434
difference was observed in the bacterial loads between AF samples and negative
435
controls.28
436 437
In addition, using multiple inquiry methods and adequate technical controls, Theis et
438
al30 claimed no consistent evidence to support the existence of a unique placental
439
microbiota in patients who delivered at term without labor. More recently, de Goffau et
440
al32 also provided evidence that the placenta is not colonized by microorganisms in
441
healthy pregnancies and that any bacterial signals are associated with contamination
442
DNA and/or batch effects. Consistent with previous studies by Rowlands et al,50
443
Rehbinder et al,28 and Lim et al,29 our study included multiple technical controls and
444
multiple complementary methods of inquiry: bacterial culture, 16S rRNA gene qPCR
445
and 16S rRNA gene sequencing, and provided the robust evidence of the “sterile
446
womb”
447 448
Bacterial culture
449
Consistent with recent studies,28 no viable bacteria were cultured from any of AF
450
samples. Given that a positive culture of AF samples is the sign of MIAC,39,41 and that
451
no intra-amniotic inflammatory response was identified during the cytokines detection,
452
our study supported a sterile intra-amniotic environment at midtrimester.
453 454
qPCR
455
In line with Lim et al,29 the 16S rRNA gene copy numbers in AF were much lower than
456
those in stool samples and vaginal swabs. When compared with the negative controls,
457
the microbial abundance in AF was similar to that of the sampling controls, but higher
458
than that of the laboratory controls, indicating extra contributions of contamination
459
during the sampling process.
460 461
16S rRNA gene sequencing
462
Based on 16S rRNA gene sequencing, the bacterial richness and community 14
463
structure were similar between the negative controls and AF samples, which was
464
consistent with previous studies revealing that the amniotic cavity is sterile in
465
uncomplicated pregnancies.28,29,50 In the secondary analysis of the same data, 4
466
bacterial
467
Ruminococcus, were identified against the negative controls. As typical inhabitants in
468
the human vagina, gut or skin niches, these bacterial signals are considered to be
469
ecologically plausible. The
470
been identified in endometrium,11,12 and Propionibacterium in umbilical cord blood of
471
healthy newborn51 and chorioamnion sample of healthy pregnancies,52 suggesting the
472
possibility that these human commensal bacteria may enter the amniotic cavity
473
though ascending pathway or hematogenous dissemination.15,16
signals,
Bacteroides,
Propionibacterium,
Faecalibacterium
and
Bacteroides, Faecalibacterium and Ruminococcus have
474 475
It is noteworthy that 87.5% (7/8) of the women who harbored the four bacterial signals
476
conceived through IVF (Table 2), which may be associated with the different profiles of
477
physiology, immunology and endocrinology in the IVF pregnancies. The process of
478
IVF treatment is complicated.53 Various cytokines are involved in the balance between
479
the immunogenic resistance and tolerance.54 The exogenous estrogen and
480
progesterone in IVF treatment are associated with the risk of microbial invasion, as
481
microbes can alter and utilize host hormones to facilitate growth and survival.55 In
482
addition, IVF women are exposed to more invasive operations, such as cervical
483
excision procedures, hysteroscopic resection or induced abortion, as well as the IVF
484
treatment itself,56 which may be a route for MIAC.24 In current study, it is hard to
485
untangle the key contributors to the identification of four bacterial signals.
486 487
Cytokine profiles
488
MIAC is frequently accompanied by the presence of high AF concentration of
489
cytokines and chemokines, such as IL-1,57-59 IL-6,35,60-64 IL-8,65,66 IP-10,35,64,67 and
490
other inflammation-related proteins.68-70 The IL-6 plays a key role in diagnosis of
491
intra-amniotic inflammation, given the strong association with preterm labor and an
492
increased rate of neonatal morbidity and mortality.61,71,72 IL-1 has been implicated as a
493
signal for the onset of human parturition in the setting of infection,57 and the IL-1α
494
serves as an alarmin and plays a core role in the microbial-associated intra-amniotic
495
inflammation.72 15
496 497
Although there is a wide range of cutoffs in AF IL-6 levels for intra-amniotic
498
inflammation,61-65,71,73 any AF samples from our study did not reach the threshold
499
described in previous studies, indicating the absence of intra-amniotic inflammatory
500
response.
501
chorioamnionitis was observed in women with four bacterial signals. Therefore, no
502
further comparison was conducted. In current study, we did not find sufficient
503
evidence to support the presence of bacterial signals identified in 16S rRNA gene
504
sequencing.
Besides,
no
spontaneous
preterm
delivery
or
histopathologic
505 506
Criteria for a genuine signal
507
In combination with all previous reports, we listed the criteria of microorganisms in AF:
508
(1) absence in negative controls; (2) the 16S rRNA gene copies and microbial profiles
509
of AF are distinct from those of negative controls; (3) the presence in at least two AF
510
samples to exclude the accidental signals; (4) ecological plausibility; (5) confirmation
511
of cytokines detection; (6) using of positive controls to clarify the lowest limit of
512
detection.
513 514
Clinical implications
515
MIAC resulting in intra-amniotic inflammation or infection is a risk factor for
516
spontaneous preterm birth.17,19,74 Recent study found that the bacteria cultured from
517
amniotic fluid of women with intra-amniotic infection were identified in the vagina,
518
providing the direct evidence of ascending infection as the primary cause of
519
intra-amniotic infection.24 In our study, the MIAC is absent at midtrimester in
520
uncomplicated pregnancies. It is noteworthy that four ecologically plausible bacterial
521
signals are identified in parts of our AF samples, however, the AF cytokines
522
concentrations are far below the cutoff value for identifying the intra-amniotic
523
inflammation. As the intra-amniotic inflammation remains a key contributor to
524
spontaneous preterm delivery, our study emphasizes the necessity of AF cytokines
525
detection, especially when a possibly positive result appears.
526 527
Research implications
528
The oral cavity, vagina and gut are regarded as the high biomass sites. The amniotic 16
529
cavity and placenta, in contrast, are sterile or contain low microbial biomass. Thus,
530
the experimental conditions for testing the presence of bacteria in these tissues or
531
biological fluids need to be different from the approaches that have been used in high
532
biomass niches.27 In this study, not only negative and positive controls, but also
533
artificial bacterial communities consisting of both gram-positive and gram-negative
534
bacteria were included. Gram-positive bacteria served as quality controls, considering
535
that the high mechanical strength of the cell wall can be affected by different
536
extraction methods,75,76 The consistency between the expected and detected results
537
ensured the feasibility of the extraction method. To determine the lowest limit of
538
detection, the serial dilutions of artificial bacterial communities with known
539
concentrations were included. The detected bacterial compositions were consistent
540
with expectation, while the relative abundance at the genus level was not exactly the
541
same as that expected. Given the technical limitations of 16S rRNA gene sequencing,
542
metagenomic sequencing is warranted for further investigations if any bacterial
543
signals are found.
544 545
Strengths and limitations
546
There are several strengths of our study. First, a prospective cohort study is
547
conducted to collect AF samples at midtrimester, hence the potential impacts of
548
maternal-fetal complications and labor onset are avoided.77 Second, multiple
549
complementary modes of inquiry and two-step analysis of 16S rRNA sequence data
550
were performed to provide a more robust conclusion. Finally, the thorough negative
551
controls were included in this study, covering each step of the experiment. To ensure
552
the qualification accuracy, the artificial bacterial communities containing various
553
bacterial species with known abundances, instead of a single bacterium, were also
554
included.76
555 556
Nevertheless, the sample size is small and it is difficult to determine the origin of
557
bacterial signals found in AF samples. Furthermore, although the cytokine profile is
558
investigated in our study, the results of 16S rRNA gene sequencing were not validated
559
by metagenome sequencing.
560 561
Conclusion 17
562
With multiple methods of inquiry, we did not identify the presence of microorganisms
563
in midtrimester AF from the pregnancies with a normal pregnancy outcome.
564 565
Acknowledgments
566
We acknowledge Mr. Yichen Liu and Ms. Lanying Zhang (COYOTE Medical
567
Laboratory, Beijing, China) for contributing to the 16S rRNA gene sequencing data
568
analysis; Dr. Lingzhen Meng (Peking University First Hospital, Beijing, China) for
569
technical support on cultivation assays; Mr. Jiming Yin (Capital Medical University
570
Affiliated Beijing You An Hospital, Beijing, China) for technical support with the
571
multiplex bead array assay. The study was supported by the National Key
572
Technologies R&D Program (no. 2016YFC1000303), National Natural Science
573
Foundation of China (no. 81671483), and Beijing Municipal Natural Science
574
Foundation (no. 7171011, S150002).
575
References
576
1. Zhu L, Luo F, Hu W, et al. Bacterial Communities in the Womb During Healthy
577
Pregnancy. Front Microbiol. 2018;9:2163.
578
2. Wang J, Zheng J, Shi W, et al. Dysbiosis of maternal and neonatal microbiota
579
associated with gestational diabetes mellitus. Gut. 2018;67(9):1614-1625.
580
3. Stinson LF, Boyce MC, Payne MS, Keelan JA. The Not-so-Sterile Womb:
581
Evidence That the Human Fetus Is Exposed to Bacteria Prior to Birth. Front Microbiol.
582
2019;10:1124.
583
4. Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation
584
may be initiated in utero by distinct microbial communities in the placenta and
585
amniotic fluid. Sci Rep. 2016;6:23129.
586
5. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta
587
harbors a unique microbiome. Sci Transl Med. 2014;6(237):237ra265.
588
6. Doyle RM, Alber DG, Jones HE, et al. Term and preterm labour are associated
589
with distinct microbial community structures in placental membranes which are
590
independent of mode of delivery. Placenta. 2014;35(12):1099-1101.
591
7. Jones HE, Harris KA, Azizia M, et al. Differing prevalence and diversity of
592
bacterial species in fetal membranes from very preterm and term labor. PLoS One.
593
2009;4(12):e8205.
594
8. Satokari R, Gronroos T, Laitinen K, Salminen S, Isolauri E. Bifidobacterium and 18
595
Lactobacillus DNA in the human placenta. Lett Appl Microbiol. 2009;48(1):8-12.
596
9. Rautava S, Collado MC, Salminen S, Isolauri E. Probiotics modulate host-microbe
597
interaction
598
placebo-controlled trial. Neonatology. 2012;102(3):178-184.
599
10. Dong XD, Li XR, Luan JJ, et al. Bacterial communities in neonatal feces are
600
similar to mothers' placentae. Can J Infect Dis Med Microbiol. 2015;26(2):90-94.
601
11. Moreno I, Codoner FM, Vilella F, et al. Evidence that the endometrial microbiota
602
has an effect on implantation success or failure. Am J Obstet Gynecol.
603
2016;215(6):684-703.
604
12. Franasiak JM, Scott RT. Endometrial microbiome. Curr Opin Obstet Gynecol.
605
2017;29(3):146-152.
606
13. Hansen R, Scott KP, Khan S, et al. First-Pass Meconium Samples from Healthy
607
Term Vaginally-Delivered Neonates: An Analysis of the Microbiota. PLoS One.
608
2015;10(7):e0133320.
609
14. Jimenez E, Marin ML, Martin R, et al. Is meconium from healthy newborns
610
actually sterile? Res Microbiol. 2008;159(3):187-193.
611
15. Romero R, Gomez R, Chaiworapongsa T, Conoscenti G, Kim JC, Kim YM. The
612
role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol. 2001;15
613
Suppl 2:41-56.
614
16. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol.
615
1988;31(3):553-584.
616
17. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes.
617
Science. 2014;345(6198):760-765.
618
18. Watts DH, Krohn MA, Hillier SL, Eschenbach DA. The association of occult
619
amniotic fluid infection with gestational age and neonatal outcome among women in
620
preterm labor. Obstet Gynecol. 1992;79(3):351-357.
621
19. Romero R, Sirtori M, Oyarzun E, et al. Infection and labor. V. Prevalence,
622
microbiology, and clinical significance of intraamniotic infection in women with preterm
623
labor and intact membranes. Am J Obstet Gynecol. 1989;161(3):817-824.
624
20. DiGiulio DB, Romero R, Kusanovic JP, et al. Prevalence and diversity of microbes
625
in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in
626
women with preterm pre-labor rupture of membranes. Am J Reprod Immunol.
627
2010;64(1):38-57.
in
the
placenta
and
fetal
19
gut:
a
randomized,
double-blind,
628
21. Romero R, Miranda J, Chaemsaithong P, et al. Sterile and microbial-associated
629
intra-amniotic inflammation in preterm prelabor rupture of membranes. The journal of
630
maternal-fetal & neonatal medicine : the official journal of the European Association of
631
Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the
632
International Society of Perinatal Obstet. 2015;28(12):1394-1409.
633
22. Romero R, Salafia CM, Athanassiadis AP, et al. The relationship between acute
634
inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J
635
Obstet Gynecol. 1992;166(5):1382-1388.
636
23. Romero R, Miranda J, Kusanovic JP, et al. Clinical chorioamnionitis at term I:
637
microbiology of the amniotic cavity using cultivation and molecular techniques. J
638
Perinat Med. 2015;43(1):19-36.
639
24. Romero R, Gomez-Lopez N, Winters AD, et al. Evidence that intra-amniotic
640
infections are often the result of an ascending invasion - a molecular microbiological
641
study. J Perinat Med. 2019;47(9):915-931.
642
25. Perez-Munoz ME, Arrieta MC, Ramer-Tait AE, Walter J. A critical assessment of
643
the "sterile womb" and "in utero colonization" hypotheses: implications for research on
644
the pioneer infant microbiome. Microbiome. 2017;5(1):48.
645
26. de Goffau MC, Lager S, Salter SJ, et al. Recognizing the reagent microbiome. Nat
646
Microbiol. 2018;3(8):851-853.
647
27. Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS.
648
Contamination in Low Microbial Biomass Microbiome Studies: Issues and
649
Recommendations. Trends Microbiol. 2019;27(2):105-117.
650
28. Rehbinder EM, Lodrup Carlsen KC, Staff AC, et al. Is amniotic fluid of women with
651
uncomplicated term pregnancies free of bacteria? Am J Obstet Gynecol.
652
2018;219(3):289 e281-289 e212.
653
29. Lim ES, Rodriguez C, Holtz LR. Amniotic fluid from healthy term pregnancies
654
does not harbor a detectable microbial community. Microbiome. 2018;6(1):87.
655
30. Theis KR, Romero R, Winters AD, et al. Does the human placenta delivered at
656
term have a microbiota? Results of cultivation, quantitative real-time PCR, 16S rRNA
657
gene sequencing, and metagenomics. Am J Obstet Gynecol. 2019;220(3):267
658
e261-267 e239.
659
31. Lauder AP, Roche AM, Sherrill-Mix S, et al. Comparison of placenta samples with
660
contamination controls does not provide evidence for a distinct placenta microbiota. 20
661
Microbiome. 2016;4(1):29.
662
32. de Goffau MC, Lager S, Sovio U, et al. Human placenta has no microbiome but
663
can contain potential pathogens. Nature. 2019.
664
33. Integrative HMPRNC. The Integrative Human Microbiome Project. Nature.
665
2019;569(7758):641-648.
666
34. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute
667
chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.
668
Am J Obstet Gynecol. 2015;213(4 Suppl):S29-52.
669
35. Romero R, Chaemsaithong P, Chaiyasit N, et al. CXCL10 and IL-6: Markers of
670
two different forms of intra-amniotic inflammation in preterm labor. Am J Reprod
671
Immunol. 2017;78(1).
672
36. Passerini R, Cassatella MC, Salvatici M, et al. Recovery and time to growth of
673
isolates in blood culture bottles: comparison of BD Bactec Plus Aerobic/F and BD
674
Bactec Plus Anaerobic/F bottles. Scand J Infect Dis. 2014;46(4):288-293.
675
37. Ozturk S, Yildiz S, Dursun P, Yener Ilce B, Kaymaz O. Mycoplasma hominis profile
676
in women: Culture, kit, molecular diagnosis, antimicrobial resistance, and treatment.
677
Microb Pathog. 2019;135:103635.
678
38. Delgado-Baquerizo M, Oliverio AM, Brewer TE, et al. A global atlas of the
679
dominant bacteria found in soil. Science. 2018;359(6373):320-325.
680
39. Romero R, Chaemsaithong P, Korzeniewski SJ, et al. Clinical chorioamnionitis at
681
term II: the intra-amniotic inflammatory response. J Perinat Med. 2016;44(1):5-22.
682
40. Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis.
683
Clin Perinatol. 2010;37(2):339-354.
684
41. Martinez-Varea A, Romero R, Xu Y, et al. Clinical chorioamnionitis at term VII: the
685
amniotic fluid cellular immune response. J Perinat Med. 2017;45(5):523-538.
686
42. Prince AL, Ma J, Kannan PS, et al. The placental membrane microbiome is
687
altered among subjects with spontaneous preterm birth with and without
688
chorioamnionitis. Am J Obstet Gynecol. 2016;214(5):627 e621-627 e616.
689
43. Antony KM, Ma J, Mitchell KB, Racusin DA, Versalovic J, Aagaard K. The preterm
690
placental microbiome varies in association with excess maternal gestational weight
691
gain. Am J Obstet Gynecol. 2015;212(5):653 e651-616.
692
44. Li F, Chen C, Wei W, et al. The metagenome of the female upper reproductive
693
tract. Gigascience. 2018;7(10). 21
694
45. Chen C, Song X, Wei W, et al. The microbiota continuum along the female
695
reproductive tract and its relation to uterine-related diseases. Nat Commun.
696
2017;8(1):875.
697
46. Kliman HJ. Comment on "the placenta harbors a unique microbiome". Sci Transl
698
Med. 2014;6(254):254le254.
699
47. The Lancet Infectious D. Microbiome studies and "blue whales in the Himalayas".
700
Lancet Infect Dis. 2018;18(9):925.
701
48. Salter SJ, Cox MJ, Turek EM, et al. Reagent and laboratory contamination can
702
critically impact sequence-based microbiome analyses. BMC Biol. 2014;12:87.
703
49. Willyard C. Could baby's first bacteria take root before birth? Nature.
704
2018;553(7688):264-266.
705
50. Rowlands S, Danielewski JA, Tabrizi SN, Walker SP, Garland SM. Microbial
706
invasion of the amniotic cavity in midtrimester pregnancies using molecular
707
microbiology. Am J Obstet Gynecol. 2017;217(1):71 e71-71 e75.
708
51. Jimenez E, Fernandez L, Marin ML, et al. Isolation of commensal bacteria from
709
umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol.
710
2005;51(4):270-274.
711
52. Bearfield C, Davenport ES, Sivapathasundaram V, Allaker RP. Possible
712
association between amniotic fluid micro-organism infection and microflora in the
713
mouth. BJOG. 2002;109(5):527-533.
714
53. van Mourik MS, Macklon NS, Heijnen CJ. Embryonic implantation: cytokines,
715
adhesion molecules, and immune cells in establishing an implantation environment. J
716
Leukoc Biol. 2009;85(1):4-19.
717
54. Kimber SJ. Leukaemia inhibitory factor in implantation and uterine biology.
718
Reproduction. 2005;130(2):131-145.
719
55. Vom Steeg LG, Klein SL. Sex Steroids Mediate Bidirectional Interactions Between
720
Hosts and Microbes. Horm Behav. 2017;88:45-51.
721
56. Jancar N, Mihevc Ponikvar B, Tomsic S, Vrtacnik Bokal E, Korosec S. Is IVF/ICSI
722
[corrected] an Independent Risk Factor for Spontaneous Preterm Birth in Singletons?
723
A Population-Based Cohort Study. Biomed Res Int. 2018;2018:7124362.
724
57. Romero R, Mazor M, Brandt F, et al. Interleukin-1 alpha and interleukin-1 beta in
725
preterm and term human parturition. Am J Reprod Immunol. 1992;27(3-4):117-123.
726
58. Cox SM, Casey ML, MacDonald PC. Accumulation of interleukin-1beta and 22
727
interleukin-6 in amniotic fluid: a sequela of labour at term and preterm. Hum Reprod
728
Update. 1997;3(5):517-527.
729
59. Puchner K, Iavazzo C, Gourgiotis D, et al. Mid-trimester amniotic fluid interleukins
730
(IL-1beta, IL-10 and IL-18) as possible predictors of preterm delivery. In Vivo.
731
2011;25(1):141-148.
732
60. Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin 6 in
733
preterm labor. Association with infection. J Clin Invest. 1990;85(5):1392-1400.
734
61. Yoon BH, Romero R, Kim CJ, et al. Amniotic fluid interleukin-6: a sensitive test for
735
antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction
736
of perinatal morbidity. Am J Obstet Gynecol. 1995;172(3):960-970.
737
62. Kacerovsky M, Musilova I, Hornychova H, et al. Bedside assessment of amniotic
738
fluid interleukin-6 in preterm prelabor rupture of membranes. Am J Obstet Gynecol.
739
2014;211(4):385 e381-389.
740
63. Chaemsaithong P, Romero R, Korzeniewski SJ, et al. A rapid interleukin-6
741
bedside test for the identification of intra-amniotic inflammation in preterm labor with
742
intact membranes. The journal of maternal-fetal & neonatal medicine : the official
743
journal of the European Association of Perinatal Medicine, the Federation of Asia and
744
Oceania Perinatal Societies, the International Society of Perinatal Obstet.
745
2016;29(3):349-359.
746
64. Gervasi MT, Romero R, Bracalente G, et al. Midtrimester amniotic fluid
747
concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence
748
for heterogeneity of intra-amniotic inflammation and associations with spontaneous
749
early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med.
750
2012;40(4):329-343.
751
65. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor
752
necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the
753
development
754
1997;177(4):825-830.
755
66. Hsu CD, Meaddough E, Aversa K, et al. Elevated amniotic fluid levels of leukemia
756
inhibitory factor, interleukin 6, and interleukin 8 in intra-amniotic infection. Am J Obstet
757
Gynecol. 1998;179(5):1267-1270.
758
67. Chaemsaithong P, Romero R, Korzeniewski SJ, et al. A point of care test for the
759
determination of amniotic fluid interleukin-6 and the chemokine CXCL-10/IP-10. The
of
bronchopulmonary
dysplasia.
23
Am
J
Obstet
Gynecol.
760
journal of maternal-fetal & neonatal medicine : the official journal of the European
761
Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal
762
Societies, the International Society of Perinatal Obstet. 2015;28(13):1510-1519.
763
68. Chaiworapongsa T, Romero R, Espinoza J, et al. Macrophage migration inhibitory
764
factor in patients with preterm parturition and microbial invasion of the amniotic cavity.
765
The journal of maternal-fetal & neonatal medicine : the official journal of the European
766
Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal
767
Societies, the International Society of Perinatal Obstet. 2005;18(6):405-416.
768
69. Dudley DJ, Hunter C, Mitchell MD, Varner MW. Elevations of amniotic fluid
769
macrophage inflammatory protein-1 alpha concentrations in women during term and
770
preterm labor. Obstet Gynecol. 1996;87(1):94-98.
771
70. Holst RM, Laurini R, Jacobsson B, et al. Expression of cytokines and chemokines
772
in cervical and amniotic fluid: relationship to histological chorioamnionitis. The journal
773
of maternal-fetal & neonatal medicine : the official journal of the European Association
774
of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the
775
International Society of Perinatal Obstet. 2007;20(12):885-893.
776
71. Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm
777
birth in asymptomatic women: a systematic review. Obstet Gynecol. 2010;116(2 Pt
778
1):393-401.
779
72. Romero R, Grivel JC, Tarca AL, et al. Evidence of perturbations of the cytokine
780
network in preterm labor. Am J Obstet Gynecol. 2015;213(6):836 e831-836 e818.
781
73. Romero R, Yoon BH, Mazor M, et al. A comparative study of the diagnostic
782
performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram
783
stain in the detection of microbial invasion in patients with preterm premature rupture
784
of membranes. Am J Obstet Gynecol. 1993;169(4):839-851.
785
74. Yoon BH, Romero R, Moon JB, et al. Clinical significance of intra-amniotic
786
inflammation in patients with preterm labor and intact membranes. Am J Obstet
787
Gynecol. 2001;185(5):1130-1136.
788
75. McOrist AL, Jackson M, Bird AR. A comparison of five methods for extraction of
789
bacterial DNA from human faecal samples. J Microbiol Methods. 2002;50(2):131-139.
790
76. Costea PI, Zeller G, Sunagawa S, et al. Towards standards for human fecal
791
sample processing in metagenomic studies. Nat Biotechnol. 2017;35(11):1069-1076.
792
77. Seong HS, Lee SE, Kang JH, Romero R, Yoon BH. The frequency of microbial 24
793
invasion of the amniotic cavity and histologic chorioamnionitis in women at term with
794
intact membranes in the presence or absence of labor. Am J Obstet Gynecol.
795
2008;199(4):375 e371-375.
796 797 798 799 800 801 802 803 804 805 806 807
Author and article information
808
From the Department of Obstetrics and Gynecology, Peking University First Hospital,
809
Beijing, China (Drs Liu, Tong, Qin, Feng, Wang, Wang, Ma and Yang); Beijing Key
810
Laboratory of Maternal Fetal Medicine of Gestational Diabetes Mellitus, Beijing, China
811
(Drs Liu, Tong, Qin, Feng, Wang, Wang, Ma and Yang); COYOTE Medical Laboratory,
812
Beijing, China (Ms Li, Zhao; Mr Ai); Key Laboratory of Pathogenic Microbiology and
813
Immunology/ Institute of Microbiology, Chinese Academy of Science, Beijing, China
814
(Dr Zhu)
815
The study was supported by the National Key Technologies R&D Program (no.
816
2016YFC1000303), National Natural Science Foundation of China (no. 81671483),
817
and Beijing Municipal Natural Science Foundation (no. 7171011, S150002).
818
The authors report no conflicts of interest.
819
Corresponding authors: Jingmei Ma, MD, PhD,
[email protected]; Huixia Yang,
820
MD, PhD,
[email protected]
821 822 823 824 825 25
826 827 828 829 830 831 832 833 834 835 836 837 838 839 840
FIGURE 1
841
The flow chart of the study design
842 843
FIGURE 2
844
Comparison of 16S rRNA gene copy number among various sample types
845
A, Standard curves of a 10-fold dilution series (105 copies to 10 copies) of Escherichia
846
coli 16S ribosomal DNA. B, Comparison of 16S rRNA gene copy numbers among
847
various sample types. Statistical significance was assessed by the Mann-Whitney U
848
test; **P < 0.01, ***P < 0.001, ****P < 0.0001. ns, non-significant.
849
CT, cycle threshold.
850 851
FIGURE 3
852
The expected and detected compositions and relative abundances of artificial
853
bacterial communities according to 16S rRNA gene sequencing
854
A-G, the expected (left) and detected (right) bacterial relative abundance of 9 artificial
855
bacterial communities.
856 857
FIGURE 4
858
Primary analysis of 16S rRNA gene sequencing 26
859
A-B, Comparison of Chao1 (A) and Simpson (B) indexes between sample types. C,
860
Principal coordinates analysis based on unweighted UniFrac distances is shown
861
along the first two principal coordinate (PC) axes; percentages are the percent
862
variation explained by each PC axis.
863 864
FIGURE 5
865
Secondary analysis of 16S rRNA gene sequencing
866
Heat map of predominated bacterial OTUs, which have an average relative
867
abundance >1%. Asterisks indicate the bacterial OTUs is ecologically plausible.
868
IVF, in vitro fertilization.
27
TABLE 1 Clinical characteristics of the 37 study participants
Characteristics
Mean ± SD or median (IQR)
Age (years)
35.4 ± 4.4
Gravidity
2(1,2)
Parity
0(0,1)
GA at amniocentesis (weeks)
21(20,21)
GA at delivery (weeks)
39(38,39)
Birth weight (g)
3235(2743,4150)
Clinical indication, n (%) In vitro fertilization
14(37.8)
Cesarean section
24(64.9)
Preterm birth
4(10.8)
PPROM
2(5.4)
Preeclampsia
5(13.5)
Histologic chorioamnionitis
1(2.7)
SD, standard deviation; IQR, interquartile range. GA, gestational week; PPROM, preterm premature rupture of membranes.
TABLE 2 Microbiological profiles and clinical characteristics of 8 women with four bacterial signals a
Subject Predominant 16S rRNA IL-6 ID bacterial OTUs gene copies (pg/mL) 3 Bacteroides(60.8%) 3016 47.82 Faecalibacterium(8.2%) 3 Propionibacterium(30.1%) 203 42.86 Ruminococcus(23.1%) 5 Bacteroides(61.9%) 420 143.28 9 Propionibacteriu (100%) 316 N/A 10 Bacteroides(30.8%) 833 58.43
IVF/spontaneous GA at GA at conception amniocentesis delivery IVF 20 Fetal death at 22 GA IVF 20 38 IVF IVF IVF
20 21 21
11 13
Faecalibacterium(100%) 548 Ruminococcus(32.8%) 1531
102.06 132.57
IVF IVF
21 21
14 15
Bacteroides(40%) Bacteroides(100%)
N/A 144.19
IVF Spontaneous
21 21
459 4439
39 37 36 (latrogenic) 38 33 (Iatrogenic) 41 41
Pregnancy complications No
Histologic chorioamnionitis N/A
No
N/A
GDM No Gestational hypertension No Preeclampsia
N/A N/A N/A
N/A No chorioamnionitis No N/A b Clinical No chorioamnionitis chorioamnionitis
All patients (n=8) had negative cultivation results for both bacteria and mycoplasma. a
The presence of predominant bacterial OTUs among four ecologically plausible
OTUs. b
The temperature of this woman was 38°C, the heart rate was 106 beats/min, and the
leukocyte count of peripheral blood was 23,000 cells/mm3. GA, gestational age; GDM, gestational mellitus diabetes; N/A, not applicable.